RecruitingPhase 3NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Sponsor: Bristol-Myers SquibbFoxborough, MA · Newton, MA · South Dartmouth, MA · +38 more sites
RecruitingPhase 3NCT07177352Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesSponsor: Hoffmann-La RocheBoston, MA · Newton, MA · Watertown, MA · +65 more sites
RecruitingPhase 2NCT07033494A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Sponsor: Merck Sharp & Dohme LLCNewton, MA · +35 more sites
RecruitingPhase 3NCT06976216A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseSponsor: Bristol-Myers SquibbNewton, MA · +27 more sites
RecruitingPhase 3NCT07602582A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Sponsor: Eli Lilly and CompanyNewton, MA · Waltham, MA · +50 more sites